发布时间:2019-08-03 22:40 原文链接: SignalDependentRegulationofMyogenesisbyCorepressorMITR

The differentiation of muscle cells is regulated by many factors, including the MyoD/MEF2 family of transcription factors. The MyoD/MEF2 dimer binds to promoters to activate genes involved in muscle cell differentiation. One of the factors that regulates the role of MyoD/MEF2 in myogenesis is the protein MEF2-interacting transcription repressor (MITR), a transcriptional repressor. When MITR is bound to MEF2, myogenesis genes are repressed rather than being activated. The transcriptional repression by MITR occurs in part at least through interaction with the CtBP (carboxy-terminal binding protein) corepressor. The inhibitory activity of MITR is itself regulated by the calmoldulin dependent protein kinase CAMK. When CAMK is activated by factors such as IGF-1, it phosphorylates two specific residues in MITR, ser218 and ser448. Phosphorylated MITR does not bind to MEF2, but does bind to the protein 14-3-3, helping to block the repression of myogenesis. CAMK also plays a role in myogenesis through phosphorylation of histone deacetylase (HDAC, see Control of Skeletal Myogenesis pathway), in which HDAC alters chromatin to repress myogenesis. Like MITR, phosphorylation of HDAC removes the repression, allowing myogenesis to continue. MITR shares sequence homology with HDACs, but itself lacks the enzyme motif

Contributor:

REFERENCES: Zhang, C.L., McKinsey, T.A., and Olson, E.N. The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(13), 7354-9 Zhang, C.L., McKinsey, T.A., Lu, J.R., and Olson, E.N. Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J. Biol. Chem. 2001, 276(1), 35-9


相关文章

科学家将人工智能技术成功用于蛋白质复合物结构预测

蛋白质作为构成人体组织器官的支架和主要物质,在人体生命活动中起着重要作用。蛋白质的相互作用能产生许多效应,如形成特异底物作用通道、生成新的结合位点、失活、作用底物专一性和动力学变化等,细胞的代谢、信号......

发力癌症分子病理诊断,无锡臻和全资收购TissueofOrigin®

2021年9月9日,无锡臻和生物科技有限公司(以下简称“臻和科技”)与美国VyantBio公司签署TissueofOrigin®(以下简称“TOO®”)全球权益和ZL转让协议,全资收购这款唯一获FDA......

这3个杂志撤回中国学者249篇文章,包含上交、中山等名校

2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同时撤回了中国学者49篇文章。从2019年开始,Journalo......

肿瘤治疗的强心剂,中国学者开发肿瘤治疗新策略

磷酸甘油酸突变酶1(PGAM1)通过其代谢活性以及与其他蛋白质(例如α平滑肌肌动蛋白(ACTA2))的相互作用,在癌症代谢和肿瘤进展中起关键作用。变构调节被认为是发现针对PGAM1的高选择性和有效抑制......

llumina宣布推出新型基因分型芯片|支持AllofUs研究计划

2018年12月6日,来自圣迭戈的消息——Illumina公司(纳斯达克股票代码:ILMN)今天宣布推出新型高密度基因分型芯片Infinium™GlobalDiversityArray。这款芯片设计源......

SDSPAGE异常电泳现象及分析SDSPAGEHallofShame

SDS-PAGE异常电泳现象及分析SDS-PAGEHallofShame.pdf  很不错的东东~~推荐下~......

Preparationofdenaturing6%

Preparationofdenaturing6%polyacrylamidegelsformicrosatelliteanalysis(alsoforSSAP,high-resolutionIRAP......